<DOC>
	<DOCNO>NCT00002003</DOCNO>
	<brief_summary>To determine efficacy toxicity combination mitoxantrone hydrochloride ( Novantrone ) etoposide treatment patient HIV associate lymphoma .</brief_summary>
	<brief_title>Phase II Study Novantrone ( R ) ( Mitoxantrone ) Etoposide Patients With HIV Associated Large Cell Immunoblastic Lymphomas</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Plasmablastic Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Large-Cell , Immunoblastic</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Mitoxantrone</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<criteria>Inclusion Criteria Patients must follow : Positive HIV antibody , positive HIV culture antigen capture , prior diagnosis AIDS CDC criterion . Diagnosis pathological examination large cell immunoblastic lymphoma within measurable evaluable disease . Pneumocystis carinii pneumonia ( PCP ) prophylaxis course study . Signed write informed consent . Exclusion Criteria Coexisting Condition : Patients follow condition symptom exclude : Acute intercurrent opportunistic infection , Pneumocystis carinii pneumonia ( PCP ) diagnose within 3 week . Stage IE Central Nervous System lymphoma . Patients follow exclude : More one previous treatment lymphoma . Acute intercurrent opportunistic infection , Pneumocystis carinii pneumonia ( PCP ) diagnose within 3 week . Conditions preclude obtain inform consent . Not accessible schedule treatment visit followup . Stage IE Central Nervous System ( CNS ) lymphoma . Prior Medication : Excluded within 2 week study entry : Zidovudine . Excluded : Doxorubicin dose = &gt; 300 mg/m2 . Prior Treatment : Excluded : Received one previous treatment regimen lymphoma . Required : Prophylactic treatment Pneumocystis carinii pneumonia ( PCP ) prophylaxis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 1992</verification_date>
	<keyword>Mitoxantrone</keyword>
	<keyword>Lymphoma , Large-Cell</keyword>
	<keyword>Etoposide</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
</DOC>